ANS Wins Medical Design Excellence Award for Axxess Product Line Neurostimulation Leads Recognized in MDEA Awards for Product Design and Engineering PLANO, Texas, April 11 /PRNewswire-FirstCall/ -- Advanced Neuromodulation Systems, Inc. (NASDAQ:ANSI) today announced that its line of Axxess(R) neurostimulation leads, designed for superior handling and precise placement, has received a 2005 Medical Design Excellence Award (MDEA). The MDEA competition is sponsored by Medical Device & Diagnostic Industry (MD&DI) magazine and organized by Canon Communications LLC, Los Angeles. "We are honored to be recognized for medical innovation in the design and engineering of our Axxess leads," said Chris Chavez, ANS president and CEO. "Axxess leads represent not only advanced neurostimulation lead technology and design, but a significant leap forward in specialized miniaturization capabilities and manufacturing processes. The resulting size and steerability of our Axxess leads benefit both doctors and their patients." Axxess neurostimulation leads set a new standard by offering the smallest diameter available -- 36% thinner than other neurostimulation leads on the market. The patented unibody design for optimum steerability is designed to make implantation faster and easier for the physician and less invasive for the patient. Additionally, the increased maneuverability allows for greater placement alternatives to effectively treat chronic pain. Axxess leads are available in multiple lengths and electrode configurations, providing physicians options when customizing treatments to the individual needs of the patient. The leads' low impedance design also helps increase the longevity of ANS' neurostimulation systems -- Genesis(R), GenesisXP(TM), GenesisRC(TM), Eon(TM) and Renew(R) spinal cord stimulation systems. MDEA is the only awards program that exclusively recognizes contributions to and advances in medical product design. Award entries are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced patient benefits, and the product development team's ability to overcome design and engineering challenges so that the product meets its clinical objectives. The 2005 Medical Design Excellence Award winners will be honored at a ceremony during the Medical Design & Manufacturing (MD&M) East Conference and Exposition, June 13-15, 2005, at New York City's Jacob K. Javits Convention Center. Gold and silver recipients will be announced at this time. About Advanced Neuromodulation Systems (ANS) Advanced Neuromodulation Systems, Inc. designs, develops, manufactures and markets implantable systems used to manage chronic intractable pain and other disorders of the central nervous system. A technology leader in the neuromodulation industry, ANS offers a family of proprietary neurostimulation devices and implantable drug pumps for an expanding range of therapeutic applications. ANS was recently named among FORTUNE's 100 Fastest Growing Companies and has been recognized among Forbes' 200 Best Small Companies for two consecutive years. Frost & Sullivan also honored the company with its Product Innovation Award. Additional information is available at http://www.ans-medical.com/ . About Medical Design Excellence Awards The MDEA program is presented by Canon Communications LLC and supported by the Human Factors and Ergonomics Society, an interdisciplinary organization of professionals involved in the human factors field. For more information about the Medical Design Excellence Awards -- including additional details about the manufacturers and suppliers that created the 2005 MDEA-winning products -- visit the MDEA Web site at http://www.mdeawards.com/ or e-mail: . DATASOURCE: Advanced Neuromodulation Systems, Inc. CONTACT: Brooke Haneborg of Advanced Neuromodulation Systems, Inc., +1-972-309-8132, or Web site: http://www.ans-medical.com/ http://www.mdeawards.com/

Copyright

Advanced Neuromodulation (NASDAQ:ANSI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Advanced Neuromodulation.
Advanced Neuromodulation (NASDAQ:ANSI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Advanced Neuromodulation.